Reverse phase protein array (RPPA) is a high-throughput technology that performs protein assays on thousands of samples simultaneously, including tissue and cell lysates, serum, plasma or other body ...

Protein arrays are a relatively new technique for studying protein-protein interactions and profiling antibody binding and specificity, and in the past year a number of companies have released premade ...

Researchers in the laboratory of R. Graham Cooks at Purdue University have developed a mass spectrometry-based method of creating protein arrays. The technique, known as ion soft-landing, selects ...

High-Throughput and Multiplexed Assays Augment Biomarker Discovery and Diagnostics High-throughput proteomics using microarray-based technology and proteome chips is accelerating protein-biomarker ...

Cancer is one of the leading causes of death worldwide, affecting over 20 million individuals and killing 9.7 million in 2022 alone. Each of ~200 cancer types (and multiple subtypes) presents an ...

An Integral Molecular scientist screens antibody drugs for specificity using the Membrane Proteome Array™, a high-throughput, cell-based, protein array technology. Integral Molecular, a leader in ...

Scientists at Northwestern University have developed a new detection technology on the nanometer scale that could lead to the next generation of proteomic arrays and new methods for diagnosing ...